Year Item Type Full Text

Bibliographic data only

Cost and cost effectiveness of Herpes simplex virus-type 2 (hsv-2) suppressive therapy in HIV-1 and HSV-2 infected women in Johannesburg, South Africa. (2009) Devine, A; Meyer-Rath, G; Foss, A; Vickerman, P; Edwards, M; Bachmann, M; Mayaud, P; Delany-Moretlwe, S

Could HSV-2 suppressive therapy using valacyclovir be a cost-effective strategy for reducing HIV disease progression and transmission among HIV-1 infected women in South Africa? (2012) Vickerman, P; Devine, A; Foss, A; Delany-Moretlwe, S; Mayaud, P; Meyer-Rath, G

Modelling the cost-effectiveness of HSV-2 suppressive therapy for reducing HIV progression and infectivity among HIV infected women in South Africa. (2009) Vickerman, P; Devine, A; Meyer-Rath, G; Foss, A; Delany-Moretlwe, S; Mayaud, P